308-313 (Elsevier)
Often combined with microinfusion during recovery, not in place of it
Rotating between abdomen, thigh, and upper arm sites ensures optimal medication delivery
Study 2: SELECT Trial Duration : 208 weeks (4 years) Findings : Semaglutide users sustained a weight reduction of 10.2% from baseline versus 1.5% with placebo
Both studies began recruitment in late 2024 with Ametrine-2 primary completion estimated for June 2027 and study completion for both trials estimated for December 2029, recruiting across 152 locations worldwide including major medical centers in the United States, Europe, Asia, and other regions, though no results are yet available
Along with gastrointestinal side effects arising from changes in appetite and diet, some patients also experience headaches and fatigue